T2 Biosystems Company Profile (NASDAQ:TTOO)

About T2 Biosystems

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.

Industry, Sector and Symbol:

Sector: Medical
Industry: Medical Appliances & Equipment
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: TTOO
CUSIP:

Key Metrics:

Previous Close: $7.24
50 Day Moving Average: $6.92
200 Day Moving Average: $7.89
52-Week Range: $4.92 - $12.30
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -4.47
P/E Growth: 0.00
Market Cap: $176.40M
Outstanding Shares: 24,364,000
Beta: 1.75

Profitability:

Net Margins: -1,233.67%
Return on Equity: -159.25%
Return on Assets: -72.84%

Debt:

Debt-to-Equity Ratio: 1.11%
Current Ratio: 3.00%
Quick Ratio: 2.92%

Additional Links:

Companies Related to T2 Biosystems:

Consensus Ratings for T2 Biosystems (NASDAQ:TTOO) (?)

Ratings Breakdown:	1 Sell Rating, 4 Hold Ratings, 3 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:	Hold (Score: 2.44)
Consensus Price Target:	$10.93 (50.91% upside)

Analysts' Ratings History for T2 Biosystems (NASDAQ:TTOO)

Show:

Date	Firm	Action	Rating	Price Target
9/22/2016	Canaccord Genuity	Reiterated Rating	Buy	$9.00
7/20/2016	WBB Securities	Upgrade	Buy -> Strong-Buy	$11.00 -> $12.00
7/10/2016	Leerink Swann	Reiterated Rating	Buy
7/9/2016	Cantor Fitzgerald	Reiterated Rating	Buy
7/9/2016	Janney Montgomery Scott	Reiterated Rating	Hold
7/8/2016	BTIG Research	Downgrade	Buy -> Sell	$12.00 -> $4.00
5/2/2016	Morgan Stanley	Reiterated Rating	Hold
12/22/2015	Goldman Sachs Group Inc.	Boost Price Target	Neutral	$13.00 -> $14.00
11/3/2015	Jefferies Group	Reiterated Rating	Buy -> Fair Value	$21.00 -> $11.48

(Data available from 9/30/2014 forward)

Earnings History for T2 Biosystems (NASDAQ:TTOO)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/31/2016
8/1/2016	Q2	($0.56)	($0.58)	$1.53 million	$0.99 million	View	N/A
5/2/2016	Q1	($0.54)	($0.55)		$1.10 million	View	N/A
2/16/2016	Q4	($0.59)	($0.56)	$1.21 million	$1.01 million	View	Listen
11/2/2015	Q3	($0.59)	($0.57)	$0.66 million	$1.05 million	View	N/A
8/4/2015	Q215	($0.57)	($0.54)	$0.34 million	$0.56 million	View	N/A
5/5/2015	Q115	($0.57)	($0.53)	$0.22 million	$0.19 million	View	N/A
2/17/2015	Q414	($0.44)	($0.45)			View	N/A
11/4/2014	Q314	($0.58)	($0.71)			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for T2 Biosystems (NASDAQ:TTOO)

Current Year EPS Consensus Estimate: $-2.18 EPS
Next Year EPS Consensus Estimate: $-1.62 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.59)	($0.55)	($0.57)
Q2 2016	3	($0.57)	($0.54)	($0.55)
Q3 2016	3	($0.53)	($0.52)	($0.53)
Q4 2016	3	($0.51)	($0.46)	($0.48)

(Data provided by Zacks Investment Research)

Dividend History for T2 Biosystems (NASDAQ:TTOO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for T2 Biosystems (NASDAQ:TTOO)

Insider Ownership Percentage: 43.20%
Institutional Ownership Percentage: 80.44%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
6/30/2016	Rahul Dhanda	SVP	Sell	3,589	$8.16	$29,286.24
3/16/2016	Rahul Dhanda	SVP	Sell	7,588	$8.01	$60,779.88
12/9/2015	Aisling Capital Iii Lp	Major Shareholder	Buy	307,692	$9.75	$2,999,997.00
12/9/2015	David B Elsbree	Director	Buy	10,000	$9.75	$97,500.00
7/24/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	15,399	$15.04	$231,600.96
7/22/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$15.22	$228,284.78
7/21/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$15.42	$231,284.58
7/20/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$16.05	$240,733.95
7/17/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	44,997	$16.26	$731,651.22
7/14/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	29,998	$16.57	$497,066.86
7/10/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	44,997	$16.25	$731,201.25
7/10/2015	Thomas J Lowery	Insider	Sell	2,000	$16.03	$32,060.00
7/7/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	44,997	$15.91	$715,902.27
7/1/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	44,997	$16.09	$724,001.73
6/30/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$16.22	$243,283.78
6/29/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$16.28	$244,183.72
6/26/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	44,997	$17.08	$768,548.76
6/23/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	29,998	$18.18	$545,363.64
6/22/2015	Polaris Venture Partners V, L.	Major Shareholder	Sell	14,999	$18.22	$273,281.78
6/18/2015	Thomas J Lowery	Insider	Sell	1,000	$18.65	$18,650.00
6/12/2015	Michael J Cima	Director	Buy	1,000	$18.91	$18,910.00
6/12/2015	Thomas J Lowery	Insider	Sell	1,471	$18.55	$27,287.05
5/8/2015	Michael A Pfaller	Insider	Sell	15,440	$16.31	$251,826.40
4/20/2015	Thomas J Lowery	Insider	Sell	1,000	$18.43	$18,430.00
3/4/2015	David B Elsbree	Director	Buy	1,450	$15.05	$21,822.50
11/13/2014	David B Elsbree	Director	Buy	1,500	$14.75	$22,125.00
8/12/2014	Aisling Capital Iii Lp	Major Shareholder	Buy	454,545	$11.00	$4,999,995.00
8/12/2014	Sarah O Kalil	COO	Buy	15,000	$11.00	$165,000.00
8/12/2014	Thomas J Carella	Director	Buy	909,090	$11.00	$9,999,990.00

(Data available from 1/1/2013 forward)

Latest Headlines for T2 Biosystems (NASDAQ:TTOO)

Date	Headline
	Broker Changes For T2 Biosystems, Inc. (TTOO) - NewsDen (NASDAQ:TTOO) newsden.net - September 28 at 8:53 AM
	T2 Biosystems, Inc. (NASDAQ:TTOO)'s Expectation Of $68.575 In Sales - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - September 25 at 6:37 PM
	Consensus Estimates on Earnings & Stock Price in Focus for T2 Biosystems, Inc. (NASDAQ:TTOO) Shares - Frisco Fastball (NASDAQ:TTOO) friscofastball.com - September 25 at 6:37 PM
	T2 Biosystems : to Present at Upcoming Investor Conferences (NASDAQ:TTOO) www.4-traders.com - September 24 at 6:56 PM
	Time to Buy T2 Biosystems Inc After Today's Huge Increase? - Post News (NASDAQ:TTOO) www.kentuckypostnews.com - September 24 at 8:34 AM
	Stocks in News: T2 Biosystems, Inc. (NASDAQ:TTOO), Universal Electronics Inc. (NASDAQ:UEIC), Quaker Chemical ... - KC Register (NASDAQ:TTOO) www.kcregister.com - September 23 at 7:11 PM
	T2 Biosystems (TTOO) Announces Presentation of Data on T2MR Tech in Lyme Disease - StreetInsider.com (NASDAQ:TTOO) www.streetinsider.com - September 23 at 8:29 AM
	T2 BIOSYSTEMS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secur (NASDAQ:TTOO) biz.yahoo.com - September 22 at 7:28 PM
	T2 Biosystems (TTOO) Announces Presentation of Data on T2MR Tech in Lyme Disease (NASDAQ:TTOO) www.streetinsider.com - September 22 at 8:28 AM
	T2 Biosystems Announces $40 Million Equity Investment by Partner Canon U.S.A. (NASDAQ:TTOO) www.publicnow.com - September 22 at 8:28 AM
	T2 Biosystems Presents Data on the Company’s T2MR® Technology for the Detection of the Bacteria that … (NASDAQ:TTOO) finance.yahoo.com - September 21 at 7:19 PM
	T2 Biosystems Presents Data on the Company’s T2MR® Technology for the Detection of the Bacteria that Causes Lyme Disease Directly from Whole Blood at Cold Spring Harbor Laboratory Conference on Diagnostic Tests for Lyme Disease (NASDAQ:TTOO) finance.yahoo.com - September 21 at 7:19 PM
	4:03 pm T2 Biosystems presents data on the T2MR technology for the detection of Borrelia directly from whole blood samples at the Diagnostic Tests for Lyme Disease Conference (NASDAQ:TTOO) finance.yahoo.com - September 21 at 7:19 PM
	Analysts Take the Wheel on T2 Biosystems, Inc. (NASDAQ:TTOO) Shares and Where They Might Be Headed - Frisco Fastball (NASDAQ:TTOO) friscofastball.com - September 20 at 5:13 PM
	ETF’s with exposure to T2 Biosystems, Inc. : September 19, 2016 (NASDAQ:TTOO) www.capitalcube.com - September 19 at 7:42 PM
	Expected For T2 Biosystems, Inc. (NASDAQ:TTOO) Sales Of $68.575 - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - September 18 at 7:13 PM
	T2 Biosystems, Inc. (NASDAQ:TTOO) Expects Sales Of $68.575 - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - September 12 at 8:57 AM
	The Sell-side Consensus is in on T2 Biosystems, Inc. (NASDAQ:TTOO); Earnings & Target Updates - National Daily Press (NASDAQ:TTOO) www.nationaldailypress.com - September 9 at 8:43 AM
	Placing T2 Biosystems, Inc. (NASDAQ:TTOO) Shares Under the Microscope - Post News (NASDAQ:TTOO) www.kentuckypostnews.com - September 7 at 7:55 PM
	T2 BIOSYSTEMS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:TTOO) biz.yahoo.com - September 7 at 7:55 PM
	T2 Biosystems, Inc. (NASDAQ:TTOO) Expects To Hit Sales Of $68.575 - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - September 4 at 6:53 PM
	T2 Biosystems to Present at Upcoming Investor Conferences (NASDAQ:TTOO) www.publicnow.com - September 1 at 11:03 AM
	New Report Available: T2 Biosystems, Inc. (TTOO) - Financial and Strategic SWOT Analysis Review (NASDAQ:TTOO) www.live-pr.com - August 26 at 10:49 AM
	How is the Crowd Rating T2 Biosystems, Inc. (NASDAQ:TTOO) Shares? - Post News (NASDAQ:TTOO) www.kentuckypostnews.com - August 24 at 7:40 PM
	Analysts See Sales Of $68.575 For T2 Biosystems, Inc. (NASDAQ:TTOO) - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - August 22 at 8:59 AM
	Stock Tracking Lower for the Quarter: T2 Biosystems, Inc. (NASDAQ:TTOO) - Post News (NASDAQ:TTOO) www.kentuckypostnews.com - August 20 at 7:27 PM
	ETF’s with exposure to T2 Biosystems, Inc. : August 19, 2016 (NASDAQ:TTOO) www.capitalcube.com - August 19 at 7:46 PM
	T2 BIOSYSTEMS, INC. Financials (NASDAQ:TTOO) finance.yahoo.com - August 17 at 8:15 PM
	ETF’s with exposure to T2 Biosystems, Inc. : August 8, 2016 (NASDAQ:TTOO) www.capitalcube.com - August 8 at 8:10 PM
	T2 BIOSYSTEMS, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:TTOO) biz.yahoo.com - August 8 at 8:10 PM
	T2 Biosystems, Inc. (NASDAQ:TTOO) Yearly Sales Target At $68.575 - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - August 7 at 7:31 PM
	T2 Biosystems, Inc. :TTOO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:TTOO) www.capitalcube.com - August 5 at 8:10 PM
	T2 Biosystems to Present at the Canaccord Genuity Growth Conference (NASDAQ:TTOO) finance.yahoo.com - August 4 at 11:12 AM
	T2 BIOSYSTEMS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib (NASDAQ:TTOO) biz.yahoo.com - August 3 at 8:19 PM
	T2 Biosystems Inc. (TTOO) is Trading Higher on Unusual Volume for August 01 - Equities.com (NASDAQ:TTOO) www.equities.com - August 3 at 11:16 AM
	Biggest Moving Companies After the Bell (NASDAQ:TTOO) www.fxpips.com - August 2 at 9:03 AM
	Edited Transcript of TTOO earnings conference call or presentation 1-Aug-16 8:30pm GMT (NASDAQ:TTOO) finance.yahoo.com - August 2 at 9:03 AM
	T2 Biosystems reports 2Q loss (NASDAQ:TTOO) sg.finance.yahoo.com - August 1 at 7:44 PM
	Q2 2016 T2 Biosystems Inc Earnings Release - After Market Close (NASDAQ:TTOO) biz.yahoo.com - August 1 at 7:07 AM
	WBB Securities Upgrades T2 Biosystems Inc to Strong Buy - Trade Calls (NASDAQ:TTOO) www.tradecalls.org - July 29 at 8:13 PM
	T2 Biosystems, Inc. (NASDAQ:TTOO) Expected To Post Sales Of $120.843 - Investor Newswire (NASDAQ:TTOO) www.investornewswire.com - July 26 at 8:27 PM
	T2 Biosystems Inc Declines Again; Strong Momentum for Sellers - Consumer Eagle (NASDAQ:TTOO) www.consumereagle.com - July 22 at 7:48 PM
	Equity Roundup: Stock Performance Focus on T2 Biosystems, Inc. (NASDAQ:TTOO) - Press Telegraph (NASDAQ:TTOO) presstelegraph.com - July 22 at 10:52 AM
	Analysts Upgrade of the Day: T2 Biosystems Inc (NASDAQ:TTOO) - Review Fortune (NASDAQ:TTOO) reviewfortune.com - July 22 at 10:52 AM
	T2 Biosystems Inc. (TTOO) is Trading Higher on Unusual Volume for July 20 - Equities.com (NASDAQ:TTOO) www.equities.com - July 22 at 10:52 AM
	T2 Biosystems Announces 2016 Second Quarter and Six-Month Results Release and Conference Call Date (NASDAQ:TTOO) www.4-traders.com - July 21 at 10:46 AM
	Shares Jumping Higher in Session: T2 Biosystems, Inc. (NASDAQ:TTOO) - TGP (NASDAQ:TTOO) telanaganapress.com - July 20 at 9:00 PM
	How Many T2 Biosystems Inc (NASDAQ:TTOO)'s Analysts Are Bullish? - Consumer Eagle (NASDAQ:TTOO) www.consumereagle.com - July 20 at 10:49 AM
	T2 Biosystems (TTOO) Enters Agreement with Bayer to Provide T2MR - StreetInsider.com (NASDAQ:TTOO) www.streetinsider.com - July 20 at 10:49 AM
	T2 Biosystems upgraded by WBB Securities (NASDAQ:TTOO) finance.yahoo.com - July 20 at 8:11 AM